Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04763876 · ClinicalTrials.gov registry record · Phase 4
Intramuscular Ketorolac at Two Single-Dose Regimens
A Phase 4 study, sponsored by William Beaumont Army Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 110
- Enrollment target
NCT04763876: Completed Phase 4 study, sponsored by William Beaumont Army Medical Center.
NCT04763876 is a Phase 4 study that has completed, run by William Beaumont Army Medical Center. The registered enrollment target is 110 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04763876, a Phase 4 study, has completed, sponsored by William Beaumont Army Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 110 participants
- Enrollment target
Study Summary
The purpose of this study was to evaluate a single 15 mg intramuscular (IM) dose of ketorolac for analgesic non-inferiority versus a single 60 mg IM dose for the treatment of acute MSK pain in a military emergency department (ED) that services Department of Defense (DoD), Department of Veteran Affairs (VA), and foreign military beneficiaries
Primary Outcome
The mean difference of Visual Analog Scale scores between the two treatment groups measured at 60-minutes. The Visual Analog Scale used measures from 0 mm to 100mm. A higher score represents more degree of change. 13 mm was used as the non-inferiority margin. A difference between the two groups less than 13 mm demonstrates that 15 mg is non-inferior to 60 mg.
Interventions
- DRUG Ketorolac Injection 15 mg
- DRUG Ketorolac Injection 60 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2020-06-27 |
| Est. Completion | 2021-02-04 |
| Phase | Phase 4 |
What the finished NCT04763876 record still lists
NCT04763876 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 2 interventions - of which Ketorolac Injection 15 mg is the first listed.
NCT04763876 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04763876 about?
NCT04763876 is a clinical study titled "Intramuscular Ketorolac at Two Single-Dose Regimens". The purpose of this study was to evaluate a single 15 mg intramuscular (IM) dose of ketorolac for analgesic non-inferiority versus a single 60 mg IM dose for the treatment of acute MSK pain in a military emergency department (ED) that services Department of Defense (DoD), Department of Veteran Affai...
What is the current status of trial NCT04763876?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 110 participants. The study started on 2020-06-27. Estimated completion is 2021-02-04.
What interventions are being tested in trial NCT04763876?
The interventions under investigation include: Ketorolac Injection 15 mg (DRUG), Ketorolac Injection 60 mg (DRUG).
Who is sponsoring clinical trial NCT04763876?
This trial is sponsored by William Beaumont Army Medical Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04763876's enrollment target sits among peer trials
110 727th of 2000 higher than 1,264 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI